Eyenovia, Inc., an ophthalmic technology company, has announced it is consulting with Chardan as its financial advisor to explore various strategic alternatives, including potential business ...

Alternatives have been the preserve of institutional investors for decades but now, more than at any other time, a confluence of factors is paving the way for individual investors to be drivers of ...

Clearside Biomedical, Inc. announced its exploration of strategic alternatives to advance its suprachoroidal drug delivery platform and maximize stockholder value. The company, which specializes in ...

Forbes contributors publish independent expert analyses and insights. At a time when established social media platforms are facing criticism and turbulence — from TikTok's temporary shutdown to Meta's ...

Shares of Mural Oncology plc (NASDAQ:MURA) are soaring Monday following the company's announcement that it will discontinue clinical development of its lead drug candidate Nemvaleukin and begin ...